Cowen and Company’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History

Cowen and Company’s Portfolio CANO.WS Stock Details CANO.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-735,414	Closed	-$36.8K	–	767
2023 Q3	$36.8K	Sell	735,414 -332,241	-31%	-$45.2K	﹤0.01%	314
2023 Q2	$224K	Buy	1,067,655 +446,574	+72%	+$112K	0.02%	206
2023 Q1	$99.4K	Sell	621,081 -387,010	-38%	-$114K	0.01%	192
2022 Q4	$222K	Buy	1,008,091 +778,108	+338%	+$675K	0.02%	169
2022 Q3	$607K	Buy	+229,983	New	+$339K	0.06%	103
2021 Q3	–	Sell	-168,671	Closed	-$622K	–	746
2021 Q2	$622K	Buy	+168,671	New	+$762K	0.03%	163

Other funds holding CANO.WS

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Cowen and Company's CANO.WS Position: Q4 2023 in Review

Cowen and Company sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q4 2023, closing a stake of 735,414 shares — an estimated $36.8K sold.

Cowen and Company first reported a position in CANO.WS in Q2 2021 and held it in 6 quarters. The position peaked at $622K in Q2 2021. 2 funds tracked by Wall St. Rank hold CANO.WS as of Q4 2023.

Cowen and Company reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q4 2023 after selling out during the quarter.
Cowen and Company sold 735,414 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q4 2023, an estimated $36.8K.
Cowen and Company first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q2 2021 and held it in 6 quarters.
Cowen and Company's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $622K in Q2 2021.
2 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q4 2023.

Based on Cowen and Company's 13F filing for Q4 2023, filed 8 Feb 2024.